Log in to post a reply
Oct 29, 2018 02:56AM
My sister had lobular carcinoma in situ dx a year before me. They gave her Tamoxifen and said the cells were precancerous. Totally confused.
Below is mine dx timeline. I was told I do not carry braca gene.
But my CA had some lobular aspects which makes it difficult to treat. Hence my confusion.
x 6/1/2009, IDC, <1cm, Grade 2, ER+/PR+, HER2-
Hormonal Therapy 6/5/2009 Arimidex (anastrozole)
Surgery 6/5/2009 Lumpectomy: RightRadiation Therapy 8/1/2009 Whole-breast: BreastHormonal Therapy 11/1/2009 Arimidex (anastrozole)
Dx 11/1/2013, IDC, 1cm, Stage IA, Grade 2, ER+/PR-, HER2+
Surgery 1/1/2014 Mastectomy: Right; Prophylactic mastectomy: Left
Targeted Therapy 2/1/2014 Herceptin (trastuzumab)
Chemotherapy ,Carboplatin (Paraplatin), Taxotere (docetaxel)
Dx 10/1/2014, IDC, <1cm, ER+/PR-, HER2-Hormonal Therapy 11/1/2014 Aromasin (exemestane)
Skin mets Sept 2015
3/2016, IDC, Right, ER+, HER2-Metastatic treatmentTypeExternalSiteChest wall radiation was finished . Pet scan then revealed left lymph node involvement. Her2- estrogen + progesterone-
Ibrance and fasoldex 2yrs
It shrunk to nothing markers normal no Ca.
But now on
10.10.18 markers up
6/1/2009, IDC, <1cm, Grade 2, ER+/PR+, HER2-
6/4/2009 Arimidex (anastrozole)
6/4/2009 Lumpectomy: Right
7/31/2009 Whole-breast: Breast
10/31/2009 Arimidex (anastrozole)
11/1/2013, IDC, 1cm, Stage IA, Grade 2, ER+/PR-, HER2+
12/31/2013 Mastectomy: Right; Prophylactic mastectomy: Left
1/31/2014 Carboplatin (Paraplatin), Taxotere (docetaxel)
1/31/2014 Herceptin (trastuzumab)
10/1/2014, IDC, Right, <1cm, ER+/PR-, HER2- (FISH)
10/31/2014 Aromasin (exemestane)
2/2016, IDC, ER+/PR-, HER2-